HLA class II, the human version of the major histocompatibility complex (MHC) class II, regulates the antitumoral cellular immune response by presenting MHC antigen in tumor cells to the immune system, stimulating tumor infiltration of CD4 + T cells80–82. The gene discussed is HLA-C; the disease is neoplasm.